From Casetext: Smarter Legal Research

In re Navidea Biopharmaceuticals Litigation

United States District Court, S.D. New York
Dec 14, 2021
19-CV-1578 (VEC) (S.D.N.Y. Dec. 14, 2021)

Opinion

19-CV-1578 (VEC)

12-14-2021

IN RE NAVIDEA BIOPHARMACEUTICALS LITIGATION


ORDER

VALERIE CAPRONI, United States District Judge:

WHEREAS a status conference was held on December 14, 2021

IT IS HEREBY ORDERED that the parties must file their respective Daubert motions, if any, by February 4, 2022. Responses are due by March 4, 2022. Replies are due by March 18, 2022.

SO ORDERED.


Summaries of

In re Navidea Biopharmaceuticals Litigation

United States District Court, S.D. New York
Dec 14, 2021
19-CV-1578 (VEC) (S.D.N.Y. Dec. 14, 2021)
Case details for

In re Navidea Biopharmaceuticals Litigation

Case Details

Full title:IN RE NAVIDEA BIOPHARMACEUTICALS LITIGATION

Court:United States District Court, S.D. New York

Date published: Dec 14, 2021

Citations

19-CV-1578 (VEC) (S.D.N.Y. Dec. 14, 2021)